Related Experiment Video
Updated: Jun 23, 2026

Measurement of Smooth Muscle Function in the Isolated Tissue Bath-applications to Pharmacology Research
Published on: January 19, 2015
Pheochromocytoma and prazosin
Prazosin effectively managed pheochromocytoma symptoms by controlling alpha-adrenergic activity. However, it was insufficient alone for surgical control, necessitating phentolamine for pressor surge suppression during procedures.
Area of Science:
- Endocrinology
- Cardiovascular Pharmacology
Background:
- Pheochromocytomas are tumors causing excessive alpha-adrenergic activity.
- Managing hypertensive crises in pheochromocytoma is critical.
Observation:
- Prazosin was administered to four patients with pheochromocytoma.
- Dosage requirements were predicted using a single low-dose prazosin challenge.
- Patients experienced reduced signs of alpha-adrenergic overactivity.
Findings:
- Prazosin alone provided inadequate control during surgical manipulation.
- Intravenous phentolamine was essential to manage tumor-induced pressor surges.
- Prazosin's utility is limited in the perioperative management of pheochromocytoma.
Implications:
- Prazosin can be a useful adjunct for long-term symptom management.
- Perioperative management of pheochromocytoma requires a multi-agent approach.
- Further research into optimal pharmacologic strategies for pheochromocytoma is warranted.
More Related Videos
Related Concept Videos
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Drugs Affecting Neurotransmitter Release or Uptake
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Antihypertensive Drugs: Vasodilators
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

